The clinical conundrum of managing relapsed small cell lung cancer

被引：1
|
作者：
Nazha, Bassel [1 ]
Owonikoko, Taofeek K. [1 ]
机构：
[1] Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA
来源：
CANCER | 2019年 / 125卷 / 07期
关键词：
PHASE-III TRIAL; OPEN-LABEL; 2ND-LINE CHEMOTHERAPY; TOPOTECAN; ETOPOSIDE; EFFICACY; MULTICENTER; RECHALLENGE; IRINOTECAN; AMRUBICIN;
D O I：
10.1002/cncr.31849
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The management of patients with relapsed/refractory small cell lung cancer is a true clinical conundrum. Using a common but challenging clinical scenario, this article discusses treatment considerations and promising emergent data on immune checkpoint inhibitor therapy and targeted therapy.
引用
收藏
页码：1022 / 1026
页数：5
相关论文
共 50 条
  • [1] Managing Patients With Relapsed Small-Cell Lung Cancer
    Gong, Jun
    Salgia, Ravi
    JOURNAL OF ONCOLOGY PRACTICE, 2018, 14 (06) : 359 - +
  • [2] Treatment of relapsed small cell lung cancer
    Postmus, PE
    Smit, EF
    SEMINARS IN ONCOLOGY, 2001, 28 (02) : 48 - 52
  • [3] Diagnostic conundrum in a patient with small cell lung cancer (SCLC)
    Parvez, Wadood
    Sudhir, Rajini
    Tufail, Muhammad
    Bennett, Jonathan
    Agrawal, Sanjay
    LUNG CANCER, 2022, 165 : S76 - S76
  • [4] Topotecan in the treatment of relapsed small cell lung cancer
    Quoix, Elisabeth
    ONCOTARGETS AND THERAPY, 2008, 1 : 79 - 86
  • [5] Lurbinectedin in the treatment of relapsed small cell lung cancer
    Baena, Javier
    Modrego, Andrea
    Zeaiter, Ali
    Kahatt, Carmen
    Alfaro, Vicente
    Jimenez-Aguilar, Elizabeth
    Mazarico, Jose Maria
    Paz-Ares, Luis
    FUTURE ONCOLOGY, 2021, 17 (18) : 2279 - 2289
  • [6] Relapsed small cell lung cancer: is more better?
    Ernani, Vinicius
    Ganti, Apar Kishor
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S1363 - S1365
  • [7] Irinotecan and carboplatin in relapsed small cell lung cancer
    Forrest, J.
    Randall, C.
    Lansdell, K.
    Earl, S.
    Cloos, B.
    Hadjiyiannakis, D.
    LUNG CANCER, 2008, 60 : S4 - S4
  • [8] A phase I clinical trial of weekly oral topotecan for relapsed small cell lung cancer
    S. Agelaki
    E. Kontopodis
    A. Kotsakis
    V. Chandrinos
    I. Bompolaki
    Ζ. Zafeiriou
    E. Papadimitraki
    D. Stoltidis
    K. Kalbakis
    V. Georgoulias
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 45 - 51
  • [9] Combination chemotherapy for relapsed small-cell lung cancer
    Kalemkerian, Gregory P.
    LANCET ONCOLOGY, 2016, 17 (08): : 1033 - 1035
  • [10] A Clinical Conundrum: Lung Cancer in the Breast
    Nakata, J. A.
    Whittall, I.
    Russo, M.
    Friedberg, J.
    Su, S.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S519 - S520
12345